OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
OrbiMed Asia III Mauritius Limited, a promoter of Entero Healthcare Solutions, has filed an annual declaration with the stock exchanges as required under Regulation 31(4) of SEBI's Takeover Regulations. The declaration states that the promoter, along with concerned parties, has not created any encumbrance (such as a pledge or lien) on the shares of Entero Healthcare Solutions during the financial year ended 31 March 2025. This is a routine yearly compliance filing by promoters, not an action involving buying, selling, or pledging shares.
This is a neutral, routine compliance filing. It reassures shareholders that the promoter has not pledged or encumbered their holdings during the year, which is mildly positive for governance confidence but unlikely to move the stock price.